Current Status of Research on Repetitive Transcranial Magnetic Stimulation for Parkinson's Disease

In recent years, repetitive transcranial magnetic stimulation (rTMS) for the treatment of Parkinson's disease (PD) has become a hot research topic both domestically and internationally, and has made many progress. Parkinson's disease is a degenerative disease of the nervous system, mainly caused by the loss of dopamine neurons and related motor and non motor symptoms. At present, drug treatment is still the main approach for Parkinson's disease, but long-term medication can lead to drug resistance and side effects, resulting in poor treatment outcomes. Therefore, it is necessary to explore new intervention measures. rTMS, as a painless and non-invasive brain stimulation therapy, has received increasing attention in the treatment of PD in recent years. The therapeutic effect and safety have also been widely recognized. This article reviews the current research status of rTMS on PD, aiming to provide reference for clinical treatment.